|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liang X, Bi S, Yang W, Wang L, Cui G, Cui
F, Zhang Y, Liu J, Gong X, Chen Y, et al: Reprint of:
Epidemiological serosurvey of Hepatitis B in China-declining HBV
prevalence due to Hepatitis B vaccination. Vaccine. 31 (Suppl
9):J21–J28. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cui Y and Jia J: Update on epidemiology of
hepatitis B and C in China. J Gastroenterol Hepatol. 28 (Suppl
1):S7–S10. 2013. View Article : Google Scholar
|
|
4
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bruix J and Sherman M; Practice Guidelines
Committee, : American Association for the Study of Liver Diseases:
Management of hepatocellular carcinoma. Hepatology. 42:1208–1236.
2015. View Article : Google Scholar
|
|
6
|
Bruix J and Sherman M; American
Association for the Study of Liver Diseases, : Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Addario L, Tritto G, Cavaglià E, Amodio F,
Giannelli E and Di Costanzo GG: Preserved liver function, portal
thrombosis and absence of oesophageal varices are risk factors for
metastasis of hepatocellular carcinoma. Dig Liver Dis. 43:319–324.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang ZM, Lai EC, Zhang C, Yu HW, Liu Z,
Wan BJ, Liu LM, Tian ZH, Deng H, Sun QH and Chen XP: The strategies
for treating primary hepatocellular carcinoma with portal vein
tumor thrombus. Int J Surg. 20:8–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kokudo T, Hasegawa K, Matsuyama Y,
Takayama T, Izumi N, Kadoya M, Kudo M, Ku Y, Sakamoto M, Nakashima
O, et al: Survival benefit of liver resection for hepatocellular
carcinoma associated with portal vein invasion. J Hepatol.
65:938–943. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
European Association for the Study of the
Liver. Electronic address, . easloffice@easloffice.eu; European
Association for the Study of the Liver: EASL 2017 clinical practice
guidelines on the management of hepatitis B virus infection. J
Hepatol. 67:370–398. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Okamura Y, Sugiura T, Ito T, Yamamoto Y,
Ashida R, Mori K and Uesaka K: Neutrophil to lymphocyte ratio as an
indicator of the malignant behaviour of hepatocellular carcinoma.
Br J Surg. 103:891–898. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu SD, Wang YY, Peng NF, Peng YC, Zhong
JH, Qin HG, Xiang BD, You XM, Ma L and Li LQ: Preoperative ratio of
neutrophils to lymphocytes predicts postresection survival in
selected patients with early or intermediate stage hepatocellular
carcinoma. Medicine (Baltimore). 95:e27222016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu X, He L, Han J, Wang L, Li M, Jiang Y,
Wang X and Yang Z: Association of neutrophil-lymphocyte ratio and T
lymphocytes with the pathogenesis and progression of HBV-associated
primary liver cancer. PLoS One. 12:e01706052017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pawarode A, Voravud N, Sriuranpong V,
Kullavanijaya P and Patt YZ: Natural history of untreated primary
hepatocellular carcinoma: A retrospective study of 157 patients. Am
J Clin Oncol. 21:386–391. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tawada A, Chiba T, Ooka Y, Kanogawa N,
Motoyama T, Saito T, Ogasawara S, Suzuki E, Maruyama H, Kanai F, et
al: Efficacy of transarterial chemoembolization targeting portal
vein tumor thrombus in patients with hepatocellular carcinoma.
Anticancer Res. 34:4231–4237. 2014.PubMed/NCBI
|
|
16
|
Villa E, Moles A, Ferretti I, Buttafoco P,
Grottola A, Del Buono M, De Santis M and Manenti F: Natural history
of inoperable hepatocellular carcinoma: Estrogen receptors' status
in the tumor is the strongest prognostic factor for survival.
Hepatology. 32:233–238. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang M, Lin Q, Wang H, Chen J, Bai M,
Wang L, Zhu K, Jiang Z, Guan S, Li Z, et al: Survival benefit of
chemoembolization plus Iodine125 seed implantation in unresectable
hepatitis B-related hepatocellular carcinoma with PVTT: A
retrospective matched cohort study. Eur Radiol. 26:3428–3436. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Byeon J, Cho EH, Kim SB and Choi DW:
Extrahepatic recurrence of hepatocellular carcinoma after curative
hepatic resection. Korean J Hepatobiliary Pancreat Surg. 16:93–97.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jun L, Zhenlin Y, Renyan G, Yizhou W,
Xuying W, Feng X, Yong X, Kui W, Jian L, Dong W, et al: Independent
factors and predictive score for extrahepatic metastasis of
hepatocellular carcinoma following curative hepatectomy.
Oncologist. 17:963–969. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Morimoto Y, Nouso K, Wada N, Takeuchi Y,
Kinugasa H, Miyahara K, Yasunaka T, Kuwaki K, Onishi H, Ikeda F, et
al: Involvement of platelets in extrahepatic metastasis of
hepatocellular carcinoma. Hepatol Res. 44:E353–E359. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee CH, Lin YJ, Lin CC, Yen CL, Shen CH,
Chang CJ and Hsieh SY: Pretreatment platelet count early predicts
extrahepatic metastasis of human hepatoma. Liver Int. 35:2327–2336.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jang WS, Cho KS, Kim MS, Yoon CY, Kang DH,
Kang YJ, Jeong WS, Ham WS and Choi YD: The prognostic significance
of postoperative neutrophil-to-lymphocyte ratio after radical
prostatectomy for localized prostate cancer. Oncotarget.
8:11778–11787. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Duan RD and Nilsson A: Metabolism of
sphingolipids in the gut and its relation to inflammation and
cancer development. Prog Lipid Res. 48:62–72. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Paramanathan A, Saxena A and Morris DL: A
systematic review and meta-analysis on the impact of pre-operative
neutrophil lymphocyte ratio on long term outcomes after curative
intent resection of solid tumours. Surg Oncol. 23:31–39. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qin M, Brummel S, Singh KK, Fenton T and
Spector SA: Associations of host genetic variants on CD4+
lymphocyte count and plasma HIV-1 RNA in antiretroviral naïve
children. Pediatr Infect Dis J. 33:946–952. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xie X, Yao M, Chen X, Lu W, Lv Q, Wang K,
Zhang L and Lu F: Reduced red blood cell count predicts poor
survival after surgery in patients with primary liver cancer.
Medicine (Baltimore). 94:e5772015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Noy R and Pollard JW: Tumor-associated
macrophages: From mechanisms to therapy. Immunity. 41:49–61. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ries CH, Cannarile MA, Hoves S, Benz J,
Wartha K, Runza V, Rey-Giraud F, Pradel LP, Feuerhake F, Klaman I,
et al: Targeting tumor-associated macrophages with anti-CSF-1R
antibody reveals a strategy for cancer therapy. Cancer Cell.
25:846–859. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tang X: Tumor-associated macrophages as
potential diagnostic and prognostic biomarkers in breast cancer.
Cancer Lett. 332:3–10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cortez-Retamozo V, Etzrodt M, Newton A,
Rauch PJ, Chudnovskiy A, Berger C, Ryan RJ, Iwamoto Y, Marinelli B,
Gorbatov R, et al: Origins of tumor-associated macrohages and
neutrophils. Proc Natl Acad Sci USA. 109:2491–2496. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chow A, Huggins M, Ahmed J, Hashimoto D,
Lucas D, Kunisaki Y, Pinho S, Leboeuf M, Noizat C, van Rooijen N,
et al: CD169+ macrophages provide a niche promoting erythropoiesis
under homeostasis and stress. Nat Med. 19:429–436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ramos P, Casu C, Gardenghi S, Breda L,
Crielaard BJ, Guy E, Marongiu MF, Gupta R, Levine RL, Abdel-Wahab
O, et al: Macrophages support pathological erythropoiesis in
polycythemia vera and β-thalassemia. Nat Med. 19:437–445. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu M, Jin X, He X, Pan L, Zhang X and
Zhao Y: Macrophages support splenic erythropoiesis in 4T1
tumor-bearing mice. PLoS One. 10:e01219212015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Eklund CM: Proinflammatory cytokines in
CRP baseline regulation. Adv Clin Chem. 48:111–136. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation and cancer. Cell. 140:883–899. 2000.
View Article : Google Scholar
|
|
36
|
Liu YB, Ying J, Kuang SJ, Jin HS, Yin Z,
Chang L, Yang H, Ou YL, Zheng JH, Zhang WD, et al: Elevated
preoperative serum Hs-CRP level as a prognostic factor in patients
who underwent resection for hepatocellular carcinoma. Medicine
(Baltimore). 94:e22092015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chan SL, Chan AW, Chan AK, Jian P, Mo F,
Chan CM, Mok K, Liu C, Chong CC, Chan AT, et al: Systematic
evaluation of circulating inflammatory markers forhepatocellular
carcinoma. Liver Int. 37:280–289. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim JM, Kwon CH, Joh JW, Ko JS, Park JB,
Lee JH, Kim SJ, Paik SW and Park CK: C-reactive protein may be a
prognostic factor in hepatocellular carcinoma with malignant portal
vein invasion. World J Surg Oncol. 11:922013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang Q, Shang L, Zang Y, Chen X, Zhang L,
Wang Y, Wang L, Liu Y, Mao S and Shen Z: α-Fetoprotein is a
potential survival predictor in hepatocellular carcinoma patients
with hepatitis B selected for liver transplantation. Eur J
Gastroenterol Hepatol. 26:544–552. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liao W, Zhang J, Zhu Q, Qin L, Yao W, Lei
B, Shi W, Yuan S, Tahir SA, Jin J and He S: Preoperative
neutrophil-to-lymphocyte ratio as a new prognostic marker in
hepatocellular carcinoma after curative resection. Transl Oncol.
7:248–255. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Choi Y, Kim JW, Cha H, Han KH and Seong J:
Overall response of both intrahepatic tumor and portal vein tumor
thrombosis is a good prognostic factor for hepatocellular carcinoma
patients receiving concurrent chemoradiotherapy. J Radiat Res.
55:113–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Huang X, Wei W, Ya N, Zeng J, Zeng Y, Ma
C, Chi M, Wu Y, Li Y, Huang Y, et al: A mathematical model to
predict short-term recurrence and metastasis of primary
hepatocellular carcinoma larger than 10 cm in diameter.
Hepatogastroenterology. 60:225–230. 2013.PubMed/NCBI
|
|
43
|
Xiang ZL, Zeng ZC, Fan J, Wu WZ, He J,
Zeng HY and Tang ZY: A clinicopathological model to predict bone
metastasis in hepatocellular carcinoma. J Cancer Res Clin Oncol.
137:1791–1797. 2011. View Article : Google Scholar : PubMed/NCBI
|
